Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06577337
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-22
Brief Title:
Single and Multiple Ascending Doses of M5542 Administered in Healthy Volunteers
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase 1 Randomized Double-Blind Placebo-Controlled Study to Evaluate the Safety Tolerability Immunogenicity and Pharmacokinetics of Single and Multiple Ascending Doses of M5542 Administered Subcutaneously in Healthy Participants
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study will evaluate the safety tolerability immunogenicity and pharmacokinetics PK of single ascending doses SAD and multiple ascending doses MAD of M5542 in healthy participants This study will be conducted in 2 parts Part A SAD and Part B MAD
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None